Vitamin D Receptor Expression in Vitiligo

Area of Science:

• Dermatology
• Endocrinology
• Immunology

Background:

• Vitiligo is a depigmenting disorder of unknown cause.
• Melanocytes are crucial for skin pigmentation.
• Vitamin D influences melanocyte function via the Vitamin D receptor (VDR).

Purpose of the Study:

• To investigate the role of Vitamin D in vitiligo pathogenesis.
• To compare Vitamin D levels and VDR gene expression in vitiligo patients and healthy controls.

Main Methods:

• A case-control study involving 30 vitiligo patients and 30 controls.
• Serum 25(OH)D levels measured by ELISA.
• VDR gene expression analyzed in skin biopsies using real-time PCR.

Main Results:

• Vitiligo patients showed significantly lower serum 25(OH)D levels compared to controls.
• A high prevalence of Vitamin D deficiency and insufficiency was observed in vitiligo patients.
• Reduced VDR-mRNA expression was found in both lesional and non-lesional skin of vitiligo patients.

Conclusions:

• Vitamin D deficiency is linked to vitiligo.
• Vitamin D may contribute to vitiligo pathogenesis through immunomodulation and effects on melanogenesis.
• VDR gene expression is decreased in vitiligo skin.